Ergebnis der Suchanfrage nach L&amp

Inhalte

Filtern
729 Treffer
  • 14.09.2006 – 11:04

    Eli Lilly and Company

    Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart

    Copenhagen, Denmark (ots/PRNewswire) - - Patients on exenatide lost weight, while insulin aspart patients gained weight - Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from a study indicating that exenatide improves blood sugar levels as effectively as biphasic insulin aspart 30/70 (NovoMix 30(R), ...

  • 13.09.2006 – 12:22

    Gemalto

    Gemalto First Half 2006 Results

    Amsterdam (ots/PRNewswire) - - Revenue[1] Up 2% at Constant Exchange Rates (-1% at Current Exchange Rates) - Operating Margin1 at 3.7%, Reflecting Fierce Competition in Mobile Communication - Cash and Cash Equivalents at USD 478 Million - Continuing Challenging Industry Environment - Synergies and Long-Term Objectives Confirmed Gemalto (Euronext NL0000400653 - GTO), a leader in digital security, today announced its results for the half year ended ...

  • 05.09.2006 – 12:35

    Boehringer Ingelheim

    Boehringer Ingelheim's pramipexole (Sifrol(R)/Mirapexin(R)) Can

    Provide Benefit of Improved Mood Disturbance for People With Restless Legs Syndrome GLASGOW, Scotland (ots) - - FOR HEALTHCARE JOURNALISTS (For media outside the US only) - New Data Shows pramipexole is an Effective Treatment Option for the Broad Range of RLS Symptoms During Both the Night and Daytime New data indicate that when treated with pramipexole (Sifrol(R)/Mirapexin(R)), ...

  • 27.07.2006 – 09:46

    Gemplus

    Gemplus Reports Further Sales Growth in the Second Quarter 2006

    Luxembourg (ots/PRNewswire) - Second quarter 2006 highlights: - Net sales up 4.7% showing good growth in ID & Security and Financial Services. - Gross margin at 32.0% reflecting strong price pressure in wireless. - Operating margin at 6.4%, sustained by good control of operating expenses. - Attributable net income: 15.1 million euros. - Distribution of reserves for 164.4 million euros ...

  • 27.07.2006 – 08:29

    Gemalto

    Gemalto Second Quarter 2006 Revenue: US$368 Million

    Amsterdam, Netherlands (ots/PRNewswire) - - Strong increase in deliveries to mobile network operators - Solid growth with financial issuers - Outstanding commercial successes in governmental identity programs The Gemalto securities referred to herein to be issued in connection with the exchange offer of Gemalto N.V. for the securities of Gemplus International S.A. have not been, and are not intended to be, ...

  • 18.07.2006 – 13:13

    Shire Pharmaceuticals Group Plc

    Fosrenol(R) Demonstrates Effective Phosphate Control With as Few as Three Tablets a Day

    Basingstoke, England (ots/PRNewswire) - - New Data Show FOSRENOL Is an Effective Monotherapy - Leading to Improved Phosphate Reduction in Dialysis Patients Previously Receiving Alternative Phosphate Binder Therapies New data show calcium-free FOSRENOL (lanthanum carbonate) further reduces phosphate levels in dialysis patients previously receiving other ...

  • 12.07.2006 – 21:38

    Montreal Exchange and the Chicago Climate Exchange

    The Montreal Climate Exchange is Established

    Montreal, Canada and Chicago (ots/PRNewswire) - - A Partnership Between the Montreal Exchange and the Chicago Climate Exchange(R) The Montreal Exchange (MX) and the Chicago Climate Exchange (CCX(R)) announced today the establishment of the Montreal Climate Exchange (MCeX), the first environmental products market in Canada. The new exchange combines the special expertise of the MX, Canada's financial derivatives ...

  • 11.07.2006 – 07:00

    Lista AG

    Capvis acquires majority stake in Lista B+L Holding

    Erlen (ots) - The majority shareholding in the Lista Workspace and Storage Systems group of companies (Lista B+L), which generated revenues of more than CHF 220 million in 2005, is being sold to private equity company Capvis. The parties involved have agreed not to disclose the price of the sale. This transaction marks a successful conclusion to the repositioning and succession planning initiated 18 months ago with the ...